immunity& immunisation
TRANSCRIPT
8/7/2019 IMMUNITY& IMMUNISATION
http://slidepdf.com/reader/full/immunity-immunisation 1/32
SASMITA K.PADHI, M.SC.NURSING-1st YEAR
GOVT.COLLEGE OF NURSING, ORISSA.
8/7/2019 IMMUNITY& IMMUNISATION
http://slidepdf.com/reader/full/immunity-immunisation 2/32
The resistance offered by the
Host towards the injury caused byforeign bodies e.g. toxic molecules
or micro-organisms
8/7/2019 IMMUNITY& IMMUNISATION
http://slidepdf.com/reader/full/immunity-immunisation 3/32
WHAT
IS
INFECTION?
8/7/2019 IMMUNITY& IMMUNISATION
http://slidepdf.com/reader/full/immunity-immunisation 4/32
Entry & development/multiplication of
an infectious agent into the host body.
It may/may not cause any illness.
8/7/2019 IMMUNITY& IMMUNISATION
http://slidepdf.com/reader/full/immunity-immunisation 5/32
IMMUNITY
INNATE ACQUIRED
8/7/2019 IMMUNITY& IMMUNISATION
http://slidepdf.com/reader/full/immunity-immunisation 6/32
INNATE/NATIVEThe resistance to infection
which is possessed by a person
individual by virtue of his genetic &
constitutional make-up.
ACQUIREDThe immunity that a
person acquires
during his/her
lifetime.
8/7/2019 IMMUNITY& IMMUNISATION
http://slidepdf.com/reader/full/immunity-immunisation 7/32
INNATE
SPECIFICNON-
SPECIFIC
8/7/2019 IMMUNITY& IMMUNISATION
http://slidepdf.com/reader/full/immunity-immunisation 8/32
NON-SPECIFIC IMMUNITY Resistance towards infection in general.
SPECIFIC IMMUNITY Resistance towards a particular
pathogen.
8/7/2019 IMMUNITY& IMMUNISATION
http://slidepdf.com/reader/full/immunity-immunisation 9/32
INNATE
SPECIES RACIAL INDIVIDUAL
8/7/2019 IMMUNITY& IMMUNISATION
http://slidepdf.com/reader/full/immunity-immunisation 10/32
The total or relative refractoriness to a
pathogen shown by all members of aspecies.
e.g. Anthrax not found in chicken.
8/7/2019 IMMUNITY& IMMUNISATION
http://slidepdf.com/reader/full/immunity-immunisation 11/32
The relative immunity shown by all the
members of a race with in a species.e.g. USA-Nigroids are more affected by TB
than USA-Caucasians
8/7/2019 IMMUNITY& IMMUNISATION
http://slidepdf.com/reader/full/immunity-immunisation 12/32
The difference in innate immunity by
different individuals of a race with in a
species.
e.g. effect of an Epidemic.
Even Heterozygous twins possess
difference.
8/7/2019 IMMUNITY& IMMUNISATION
http://slidepdf.com/reader/full/immunity-immunisation 13/32
ACQUIRED
ACTIVE
NATURAL ARTIFICIAL
PASSIVE
NATURAL ARTIFICIAL
8/7/2019 IMMUNITY& IMMUNISATION
http://slidepdf.com/reader/full/immunity-immunisation 14/32
` Resistance developed by an individual as the
result of an antigenic stimulus.
` Also called ADAPTIVE IMMUNITY
Adaptive response of the host to a
specific pathogen or other antigen.
8/7/2019 IMMUNITY& IMMUNISATION
http://slidepdf.com/reader/full/immunity-immunisation 15/32
` Results from either a clinical or an apparent
infection.
` E.g. Measles
Client recovered from measles develops
natural active immunity against measles for
lifetime.
8/7/2019 IMMUNITY& IMMUNISATION
http://slidepdf.com/reader/full/immunity-immunisation 16/32
` Resistance induced by vaccines e.g. the live/killed
micro-organisms or their products without any
virulence.
` Immunisation against 7-killer diseases.
D.P.T.,MEASELES,T.B.,TYPHOID,POLIO
8/7/2019 IMMUNITY& IMMUNISATION
http://slidepdf.com/reader/full/immunity-immunisation 17/32
` Resistance that is transmitted to the recepient in a
µReadymade¶ form & clients defence plays apassive role.
8/7/2019 IMMUNITY& IMMUNISATION
http://slidepdf.com/reader/full/immunity-immunisation 18/32
` Resistance passed from mother to the baby.
` E.g. passage of maternal antibodies to the fetusthrough placenta or to the baby through breast
milk.
8/7/2019 IMMUNITY& IMMUNISATION
http://slidepdf.com/reader/full/immunity-immunisation 19/32
` Resistance passively transferred to the recepient
by administration of antibodies.
` E.g. injection of
Preformed antibodies
Hyperimmune sera
Convalescent sera e.g.ATS,ADS.
8/7/2019 IMMUNITY& IMMUNISATION
http://slidepdf.com/reader/full/immunity-immunisation 20/32
` 1974WHO launched EPI.(Expanded programme on
immunisation).
` 1978EPI launched as UCI in India.(Universal child
immunisation).
`
1985UIP launched in India.(Universal immunisation
programme).
8/7/2019 IMMUNITY& IMMUNISATION
http://slidepdf.com/reader/full/immunity-immunisation 21/32
1. To reduce the mortality & morbidity due
to vaccine preventable diseases.
2. To achieve self-sufficiency in production
of vaccines.
8/7/2019 IMMUNITY& IMMUNISATION
http://slidepdf.com/reader/full/immunity-immunisation 22/32
7 7 - -vaccine preventable diseasesvaccine preventable diseases
` Diptheria
` Portusis` Tetanus
` Typhoid
`
Tuberculosis` Measles
8/7/2019 IMMUNITY& IMMUNISATION
http://slidepdf.com/reader/full/immunity-immunisation 23/32
MOTHER (pregnant)MOTHER (pregnant) VACCINE VACCINE
Early pregnancy TT-1st dose
After 1 month TT-2nd dose
8/7/2019 IMMUNITY& IMMUNISATION
http://slidepdf.com/reader/full/immunity-immunisation 24/32
CHILDCHILD VACCINE VACCINE
At birth BCG
OPV-0 dose
6 week DPT-1st dose
OPV-1st dose
BCG (if not given at birth)
10 week DPT-2nd dose
OPV-2nd dose
14 week DPT-3rd dose
OPV-3rd dose
9 month Measles(MMR may be given after 1month)
Vit.-A solution (To be repeated @ 6month for 4doses more)
14-24
month
DPT-Booster dose
OPV-Booster dose
8/7/2019 IMMUNITY& IMMUNISATION
http://slidepdf.com/reader/full/immunity-immunisation 25/32
ContdContd««
CHILDCHILD VACCINE VACCINE
5-6 years DT(after 1month 2nd dose)
TYPHOID
10 years TT(after 1month 2nd dose)
TYPHOID
16 years TT(after 1month 2nd dose)TYPHOID
8/7/2019 IMMUNITY& IMMUNISATION
http://slidepdf.com/reader/full/immunity-immunisation 26/32
1st dose As early as possible
2nd dose After 1month of 1st dose.
3rd dose After 5month of 2nd dose.
8/7/2019 IMMUNITY& IMMUNISATION
http://slidepdf.com/reader/full/immunity-immunisation 27/32
1-2
years
BCG At 1st visit.
OPV & DPT 3 doses in 3 visits
@4 week interval.
Measles At 3rd visit.
After
2years
BCG At 1st visit.
OPV & DT 2doses in 2 visits
@ 4week interval.
Measles/MMR/M
R
At 2nd visit.
8/7/2019 IMMUNITY& IMMUNISATION
http://slidepdf.com/reader/full/immunity-immunisation 28/32
VACCINE AMOUNT ROUTE
BCG ±At birth
at 6 week
0.05 ml
0.1 ml
ID (Lt. deltoid)
OPV 2 drops Oral
TT,DT,DPT 0.5 ml IM
Measles 0.5 ml Subcut.
Typhoid 0.15 ml Subcut.
Vit A solution-
At 9month
on subsequent doses
1 Lakh I.U.
2 Lakh I.U.
Oral
8/7/2019 IMMUNITY& IMMUNISATION
http://slidepdf.com/reader/full/immunity-immunisation 29/32
TEMP. VACCINES
Deep freezer
(-16° C to -20° C)
OPV,Measles
Ice Lined Refrigerator
(2°C to 8°C)
DPT,DT,TT,Diluents,Typ
hoid,BCG
8/7/2019 IMMUNITY& IMMUNISATION
http://slidepdf.com/reader/full/immunity-immunisation 30/32
` BCG-----Ulceration of the site
Osteomyelities
` DPT-----Fever/convulsion
Abscess of the siteEncephalities
` Measles--Neurological complications
Diarrhoea
PneumoniaOtitis media
` Opv -----Nil
8/7/2019 IMMUNITY& IMMUNISATION
http://slidepdf.com/reader/full/immunity-immunisation 31/32
OPV----nil
DPT----Progressive neurologic diseases.
Measles-Generalised eczema
OsteomyelitisInfective dermatitis
Severe cough/cold/diarrhoea/fever
Grade-3 malnutrition
BCG----ConvulsionTB / Malnutrition
Steroid therpy